Skip to main content

Pancreatic Adenosquamous Carcinoma clinical trials at UCSD

1 research study open to eligible people

Showing trials for
  • Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

    open to eligible people ages 18 years and up

    This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy drugs, such as fluorouracil, irinotecan, leucovorin, and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before and after surgery (perioperatively) may work better in treating patients with pancreatic cancer compared to giving chemotherapy after surgery (adjuvantly).

    La Jolla, California and other locations

Our lead scientists for Pancreatic Adenosquamous Carcinoma research studies include .

Last updated: